Tailored Breast Cancer Screening

Tuesday, Nov. 27, 4:30-6:00 p.m. | N227

Experts discuss the impact of the revision of the U.S. Preventive Services Task Force screening mammography guidelines in 2009, the role of screening MR for high-risk women and the use of screening breast ultrasound for women with dense breasts.

Speaker Information:

  • Daniel B. Kopans, MD, Harvard Medical School, Boston
  • D. David Dershaw, MD, Memorial Sloan-Kettering Cancer Center, New York City
  • Stephen Albert Feig, MD, University of California, Los Angeles

Around the web

GE HealthCare designed the new-look Revolution Vibe CT scanner to help hospitals and health systems embrace CCTA and improve overall efficiency.

Clinicians have been using HeartSee to diagnose and treat coronary artery disease since the technology first debuted back in 2018. These latest updates, set to roll out to existing users, are designed to improve diagnostic performance and user access.

The cardiac technologies clinicians use for CVD evaluations have changed significantly in recent years, according to a new analysis of CMS data. While some modalities are on the rise, others are being utilized much less than ever before.